1 Changes in Accounting Policies
The accounting policies applied for the financial statements as of December 31, 2009, have been used throughout the first three months of 2010.
The Group applies IFRS 8 ”Operating Segments” (effective from January 1, 2009). IFRS 8 replaces IAS 14 and aligns segment reporting with the requirements of the US standard SFAS 131 ”Disclosures about segments of an enterprise and related information”. The standard requires a ‘management approach’, under which segment information is presented on the same basis as that used for internal reporting purposes. As of June 30, 2009, the Group implemented a third operating segment, Therapeutic Antibodies – Proprietary Development.